TABLE 4.

Percent basal surface levels and 95% confidence intervals of CB₂ receptors

The results represent data obtained after treatment with select ligands (at their EC₉₀ concentrations for inhibition of adenylyl cyclase or stimulation of arrestin recruitment).

Treatment	Basal Level (Mean ± S.E.M.)	95% CI
	%
Control	99 ± 1.2	97–101
CP55940	78 ± 2.3	74– 80
2AG	99 ± 1.1	96–103
THC	100 ± 2.4	92–105
HU308	95 ± 3.3	90–103
GW833972A	69 ± 3.0	66–72
STS135	85 ± 3.3	76–89
UR144	76 ± 2.1	73–80

CI, confidence interval; GW833972A, 2-[(3-chlorophenyl)amino]-N-(4-pyridinylmethyl)-4-(trifluoromethyl)-5-pyrimidinecarboxamide hydrochloride; HU308, 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol; THC, tetrahydrocannabinol.